Aneurysm Therapeutics Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Type ( Medicine, Surgery, Other Types ); End User ( Hospitals, Clinics, Other End Users ), and Geography
Report Code: TIPRE00008955 No. of Pages: 150 Category: Medical Device Status: Upcoming
MARKET INTRODUCTION
An aneurysm is the widening of an artery that is caused by weakness in the arterial wall. An aneurysm creates an enlargement or bulge of the artery. Although the disease does not show symptoms and is not dangerous, however, a ruptured aneurysm can life-threatening internal bleeding. It has been treated by surgical intervention techniques, where the affected portion of the blood vessel can be removed. Sometimes, the medication methods are also used that involve drugs to treat the disease.
MARKET DYNAMICS
The aneurysm therapeutics market is anticipated to grow in the forecast, owing to the increasing rate of smoking among the population, high blood pressure (hypertension), and rise in the incidence of underlying diseases that increase the risk of developing aneurysms. However, the hardening of the arteries (arteriosclerosis) is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Aneurysm Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the aneurysm therapeutics market with detailed market segmentation by type, and end-user and geography. The aneurysm therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading aneurysm therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The aneurysm therapeutics market is segmented on the basis of type, and end user. On the basis of type, the market is categorized into medicine, surgical and others. Based on the end user, the market is segmented as hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry, including both qualitative and quantitative information. It provides an overview and forecast of the aneurysm therapeutics market based on various segments. It also provides market size and forecast estimates from the year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. The aneurysm therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting the aneurysm therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the aneurysm therapeutics market in these regions.
The report covers key developments in the aneurysm therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from aneurysm therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for aneurysm therapeutics market in the global market. Below mentioned is the list of few companies engaged in the aneurysm therapeutics market.
The report also includes the profiles of key aneurysm therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- GENERAL ELECTRIC COMPANY
- Terumo Corporation
- JOTEC GmbH
- Cook
- Lifetech Scientific
- Lombard Medical Limited
- Cardinal Health
- Pfizer Inc.
- Medtronic
- W. L. Gore & Associates
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
An aneurysm is the widening of an artery that is caused by weakness in the arterial wall. An aneurysm creates an enlargement or bulge of the artery. Although the disease does not show symptoms and is not dangerous, however, a ruptured aneurysm can life-threatening internal bleeding. It has been treated by surgical intervention techniques, where the affected portion of the blood vessel can be removed. Sometimes, the medication methods are also used that involve drugs to treat the disease.
MARKET DYNAMICS
The aneurysm therapeutics market is anticipated to grow in the forecast, owing to the increasing rate of smoking among the population, high blood pressure (hypertension), and rise in the incidence of underlying diseases that increase the risk of developing aneurysms. However, the hardening of the arteries (arteriosclerosis) is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Aneurysm Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the aneurysm therapeutics market with detailed market segmentation by type, and end-user and geography. The aneurysm therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading aneurysm therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The aneurysm therapeutics market is segmented on the basis of type, and end user. On the basis of type, the market is categorized into medicine, surgical and others. Based on the end user, the market is segmented as hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry, including both qualitative and quantitative information. It provides an overview and forecast of the aneurysm therapeutics market based on various segments. It also provides market size and forecast estimates from the year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. The aneurysm therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting the aneurysm therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the aneurysm therapeutics market in these regions.
The report covers key developments in the aneurysm therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from aneurysm therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for aneurysm therapeutics market in the global market. Below mentioned is the list of few companies engaged in the aneurysm therapeutics market.
The report also includes the profiles of key aneurysm therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- GENERAL ELECTRIC COMPANY
- Terumo Corporation
- JOTEC GmbH
- Cook
- Lifetech Scientific
- Lombard Medical Limited
- Cardinal Health
- Pfizer Inc.
- Medtronic
- W. L. Gore & Associates
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Aneurysm Therapeutics Market - By Type
1.3.2 Aneurysm Therapeutics Market - By End User
1.3.3 Aneurysm Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANEURYSM THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANEURYSM THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANEURYSM THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANEURYSM THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. ANEURYSM THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANEURYSM THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MEDICINE
7.3.1. Overview
7.3.2. Medicine Market Forecast and Analysis
7.4. SURGERY
7.4.1. Overview
7.4.2. Surgery Market Forecast and Analysis
7.5. OTHER TYPES
7.5.1. Overview
7.5.2. Other Types Market Forecast and Analysis
8. ANEURYSM THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHER END USERS
8.5.1. Overview
8.5.2. Other End Users Market Forecast and Analysis
9. ANEURYSM THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Aneurysm Therapeutics Market Overview
9.1.2 North America Aneurysm Therapeutics Market Forecasts and Analysis
9.1.3 North America Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.1.4 North America Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.1.5 North America Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Aneurysm Therapeutics Market
9.1.5.1.1 United States Aneurysm Therapeutics Market by Type
9.1.5.1.2 United States Aneurysm Therapeutics Market by End User
9.1.5.2 Canada Aneurysm Therapeutics Market
9.1.5.2.1 Canada Aneurysm Therapeutics Market by Type
9.1.5.2.2 Canada Aneurysm Therapeutics Market by End User
9.1.5.3 Mexico Aneurysm Therapeutics Market
9.1.5.3.1 Mexico Aneurysm Therapeutics Market by Type
9.1.5.3.2 Mexico Aneurysm Therapeutics Market by End User
9.2. EUROPE
9.2.1 Europe Aneurysm Therapeutics Market Overview
9.2.2 Europe Aneurysm Therapeutics Market Forecasts and Analysis
9.2.3 Europe Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.2.4 Europe Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.2.5 Europe Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Aneurysm Therapeutics Market
9.2.5.1.1 Germany Aneurysm Therapeutics Market by Type
9.2.5.1.2 Germany Aneurysm Therapeutics Market by End User
9.2.5.2 France Aneurysm Therapeutics Market
9.2.5.2.1 France Aneurysm Therapeutics Market by Type
9.2.5.2.2 France Aneurysm Therapeutics Market by End User
9.2.5.3 Italy Aneurysm Therapeutics Market
9.2.5.3.1 Italy Aneurysm Therapeutics Market by Type
9.2.5.3.2 Italy Aneurysm Therapeutics Market by End User
9.2.5.4 Spain Aneurysm Therapeutics Market
9.2.5.4.1 Spain Aneurysm Therapeutics Market by Type
9.2.5.4.2 Spain Aneurysm Therapeutics Market by End User
9.2.5.5 United Kingdom Aneurysm Therapeutics Market
9.2.5.5.1 United Kingdom Aneurysm Therapeutics Market by Type
9.2.5.5.2 United Kingdom Aneurysm Therapeutics Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Aneurysm Therapeutics Market Overview
9.3.2 Asia-Pacific Aneurysm Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Aneurysm Therapeutics Market
9.3.5.1.1 Australia Aneurysm Therapeutics Market by Type
9.3.5.1.2 Australia Aneurysm Therapeutics Market by End User
9.3.5.2 China Aneurysm Therapeutics Market
9.3.5.2.1 China Aneurysm Therapeutics Market by Type
9.3.5.2.2 China Aneurysm Therapeutics Market by End User
9.3.5.3 India Aneurysm Therapeutics Market
9.3.5.3.1 India Aneurysm Therapeutics Market by Type
9.3.5.3.2 India Aneurysm Therapeutics Market by End User
9.3.5.4 Japan Aneurysm Therapeutics Market
9.3.5.4.1 Japan Aneurysm Therapeutics Market by Type
9.3.5.4.2 Japan Aneurysm Therapeutics Market by End User
9.3.5.5 South Korea Aneurysm Therapeutics Market
9.3.5.5.1 South Korea Aneurysm Therapeutics Market by Type
9.3.5.5.2 South Korea Aneurysm Therapeutics Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Aneurysm Therapeutics Market Overview
9.4.2 Middle East and Africa Aneurysm Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Aneurysm Therapeutics Market
9.4.5.1.1 South Africa Aneurysm Therapeutics Market by Type
9.4.5.1.2 South Africa Aneurysm Therapeutics Market by End User
9.4.5.2 Saudi Arabia Aneurysm Therapeutics Market
9.4.5.2.1 Saudi Arabia Aneurysm Therapeutics Market by Type
9.4.5.2.2 Saudi Arabia Aneurysm Therapeutics Market by End User
9.4.5.3 U.A.E Aneurysm Therapeutics Market
9.4.5.3.1 U.A.E Aneurysm Therapeutics Market by Type
9.4.5.3.2 U.A.E Aneurysm Therapeutics Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Aneurysm Therapeutics Market Overview
9.5.2 South and Central America Aneurysm Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.5.4 South and Central America Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.5.5 South and Central America Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Aneurysm Therapeutics Market
9.5.5.1.1 Brazil Aneurysm Therapeutics Market by Type
9.5.5.1.2 Brazil Aneurysm Therapeutics Market by End User
9.5.5.2 Argentina Aneurysm Therapeutics Market
9.5.5.2.1 Argentina Aneurysm Therapeutics Market by Type
9.5.5.2.2 Argentina Aneurysm Therapeutics Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANEURYSM THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. GENERAL ELECTRIC COMPANY
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. TERUMO CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. JOTEC GMBH
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. COOK
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LIFETECH SCIENTIFIC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. LOMBARD MEDICAL LIMITED
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CARDINAL HEALTH
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MEDTRONIC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. W. L. GORE AND ASSOCIATES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Aneurysm Therapeutics Market - By Type
1.3.2 Aneurysm Therapeutics Market - By End User
1.3.3 Aneurysm Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANEURYSM THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANEURYSM THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANEURYSM THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANEURYSM THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. ANEURYSM THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANEURYSM THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MEDICINE
7.3.1. Overview
7.3.2. Medicine Market Forecast and Analysis
7.4. SURGERY
7.4.1. Overview
7.4.2. Surgery Market Forecast and Analysis
7.5. OTHER TYPES
7.5.1. Overview
7.5.2. Other Types Market Forecast and Analysis
8. ANEURYSM THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHER END USERS
8.5.1. Overview
8.5.2. Other End Users Market Forecast and Analysis
9. ANEURYSM THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Aneurysm Therapeutics Market Overview
9.1.2 North America Aneurysm Therapeutics Market Forecasts and Analysis
9.1.3 North America Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.1.4 North America Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.1.5 North America Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Aneurysm Therapeutics Market
9.1.5.1.1 United States Aneurysm Therapeutics Market by Type
9.1.5.1.2 United States Aneurysm Therapeutics Market by End User
9.1.5.2 Canada Aneurysm Therapeutics Market
9.1.5.2.1 Canada Aneurysm Therapeutics Market by Type
9.1.5.2.2 Canada Aneurysm Therapeutics Market by End User
9.1.5.3 Mexico Aneurysm Therapeutics Market
9.1.5.3.1 Mexico Aneurysm Therapeutics Market by Type
9.1.5.3.2 Mexico Aneurysm Therapeutics Market by End User
9.2. EUROPE
9.2.1 Europe Aneurysm Therapeutics Market Overview
9.2.2 Europe Aneurysm Therapeutics Market Forecasts and Analysis
9.2.3 Europe Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.2.4 Europe Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.2.5 Europe Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Aneurysm Therapeutics Market
9.2.5.1.1 Germany Aneurysm Therapeutics Market by Type
9.2.5.1.2 Germany Aneurysm Therapeutics Market by End User
9.2.5.2 France Aneurysm Therapeutics Market
9.2.5.2.1 France Aneurysm Therapeutics Market by Type
9.2.5.2.2 France Aneurysm Therapeutics Market by End User
9.2.5.3 Italy Aneurysm Therapeutics Market
9.2.5.3.1 Italy Aneurysm Therapeutics Market by Type
9.2.5.3.2 Italy Aneurysm Therapeutics Market by End User
9.2.5.4 Spain Aneurysm Therapeutics Market
9.2.5.4.1 Spain Aneurysm Therapeutics Market by Type
9.2.5.4.2 Spain Aneurysm Therapeutics Market by End User
9.2.5.5 United Kingdom Aneurysm Therapeutics Market
9.2.5.5.1 United Kingdom Aneurysm Therapeutics Market by Type
9.2.5.5.2 United Kingdom Aneurysm Therapeutics Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Aneurysm Therapeutics Market Overview
9.3.2 Asia-Pacific Aneurysm Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Aneurysm Therapeutics Market
9.3.5.1.1 Australia Aneurysm Therapeutics Market by Type
9.3.5.1.2 Australia Aneurysm Therapeutics Market by End User
9.3.5.2 China Aneurysm Therapeutics Market
9.3.5.2.1 China Aneurysm Therapeutics Market by Type
9.3.5.2.2 China Aneurysm Therapeutics Market by End User
9.3.5.3 India Aneurysm Therapeutics Market
9.3.5.3.1 India Aneurysm Therapeutics Market by Type
9.3.5.3.2 India Aneurysm Therapeutics Market by End User
9.3.5.4 Japan Aneurysm Therapeutics Market
9.3.5.4.1 Japan Aneurysm Therapeutics Market by Type
9.3.5.4.2 Japan Aneurysm Therapeutics Market by End User
9.3.5.5 South Korea Aneurysm Therapeutics Market
9.3.5.5.1 South Korea Aneurysm Therapeutics Market by Type
9.3.5.5.2 South Korea Aneurysm Therapeutics Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Aneurysm Therapeutics Market Overview
9.4.2 Middle East and Africa Aneurysm Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Aneurysm Therapeutics Market
9.4.5.1.1 South Africa Aneurysm Therapeutics Market by Type
9.4.5.1.2 South Africa Aneurysm Therapeutics Market by End User
9.4.5.2 Saudi Arabia Aneurysm Therapeutics Market
9.4.5.2.1 Saudi Arabia Aneurysm Therapeutics Market by Type
9.4.5.2.2 Saudi Arabia Aneurysm Therapeutics Market by End User
9.4.5.3 U.A.E Aneurysm Therapeutics Market
9.4.5.3.1 U.A.E Aneurysm Therapeutics Market by Type
9.4.5.3.2 U.A.E Aneurysm Therapeutics Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Aneurysm Therapeutics Market Overview
9.5.2 South and Central America Aneurysm Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.5.4 South and Central America Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.5.5 South and Central America Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Aneurysm Therapeutics Market
9.5.5.1.1 Brazil Aneurysm Therapeutics Market by Type
9.5.5.1.2 Brazil Aneurysm Therapeutics Market by End User
9.5.5.2 Argentina Aneurysm Therapeutics Market
9.5.5.2.1 Argentina Aneurysm Therapeutics Market by Type
9.5.5.2.2 Argentina Aneurysm Therapeutics Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANEURYSM THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. GENERAL ELECTRIC COMPANY
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. TERUMO CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. JOTEC GMBH
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. COOK
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LIFETECH SCIENTIFIC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. LOMBARD MEDICAL LIMITED
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CARDINAL HEALTH
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MEDTRONIC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. W. L. GORE AND ASSOCIATES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. GENERAL ELECTRIC COMPANY
2. Terumo Corporation
3. JOTEC GmbH
4. Cook
5. Lifetech Scientific
6. Lombard Medical Limited
7. Cardinal Health
8. Pfizer Inc.
9. Medtronic
10. W. L. Gore & Associates
1. GENERAL ELECTRIC COMPANY
2. Terumo Corporation
3. JOTEC GmbH
4. Cook
5. Lifetech Scientific
6. Lombard Medical Limited
7. Cardinal Health
8. Pfizer Inc.
9. Medtronic
10. W. L. Gore & Associates